DaBomb Protein Biotech Corp. (TPEX:6578)
Taiwan
· Delayed Price · Currency is TWD 18.05
-0.05 (-0.28%)
Mar 9, 2026, 1:30 PM CST
DaBomb Protein Biotech Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 1,299 | 1,334 | 1,251 | 636 | 577 | 640 | Upgrade
|
| Market Cap Growth | 2.25% | 6.64% | 96.64% | 10.20% | -9.84% | -9.34% | Upgrade
|
| Enterprise Value | 1,227 | 1,309 | 1,326 | 901 | 687 | 671 | Upgrade
|
| Last Close Price | 18.05 | 19.40 | 20.10 | 14.87 | 16.11 | 17.30 | Upgrade
|
| PE Ratio | - | 114.64 | - | - | - | 89.02 | Upgrade
|
| PS Ratio | 4.19 | 3.95 | 3.25 | 1.47 | 1.23 | 1.06 | Upgrade
|
| PB Ratio | 1.26 | 1.23 | 1.31 | 0.88 | 0.86 | 0.91 | Upgrade
|
| P/TBV Ratio | 1.27 | 1.23 | 1.31 | 0.88 | 0.86 | 0.92 | Upgrade
|
| P/FCF Ratio | - | 77.04 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 64.31 | 28.05 | 192.27 | 32.28 | - | 47.74 | Upgrade
|
| EV/Sales Ratio | 3.96 | 3.87 | 3.45 | 2.08 | 1.46 | 1.11 | Upgrade
|
| EV/EBITDA Ratio | 63.15 | 125.30 | - | - | - | 17.37 | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | - | 43.64 | Upgrade
|
| EV/FCF Ratio | -81.71 | 75.57 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.12 | 0.15 | 0.44 | 0.68 | 0.92 | 0.42 | Upgrade
|
| Debt / EBITDA Ratio | 6.23 | 14.22 | - | - | - | 7.18 | Upgrade
|
| Debt / FCF Ratio | - | 9.71 | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.07 | -0.08 | 0.04 | 0.41 | 0.62 | 0.04 | Upgrade
|
| Net Debt / EBITDA Ratio | -4.18 | -8.18 | -3.76 | -8.02 | -10.57 | 0.70 | Upgrade
|
| Net Debt / FCF Ratio | 4.76 | -4.93 | -3.03 | -1050.38 | -1.12 | -6.12 | Upgrade
|
| Asset Turnover | 0.25 | 0.25 | 0.29 | 0.33 | 0.39 | 0.61 | Upgrade
|
| Inventory Turnover | 8.99 | 9.91 | 9.26 | 9.16 | 9.62 | 10.67 | Upgrade
|
| Quick Ratio | 1.63 | 1.61 | 1.21 | 1.07 | 1.14 | 1.17 | Upgrade
|
| Current Ratio | 2.04 | 3.66 | 2.18 | 1.57 | 1.81 | 1.70 | Upgrade
|
| Return on Equity (ROE) | -2.33% | 1.14% | -6.77% | -6.37% | -9.09% | 1.03% | Upgrade
|
| Return on Assets (ROA) | -0.87% | -0.08% | -1.40% | -2.98% | -3.33% | 0.97% | Upgrade
|
| Return on Invested Capital (ROIC) | -1.83% | -0.13% | -2.96% | -5.89% | -7.00% | 1.38% | Upgrade
|
| Return on Capital Employed (ROCE) | -1.70% | -0.20% | -2.90% | -5.90% | -5.70% | 2.00% | Upgrade
|
| Earnings Yield | -1.85% | 0.87% | -4.56% | -7.02% | -10.82% | 1.12% | Upgrade
|
| FCF Yield | -1.16% | 1.30% | -0.99% | -0.04% | -65.19% | -0.69% | Upgrade
|
| Dividend Yield | 2.21% | 2.06% | 2.74% | 6.73% | - | 1.05% | Upgrade
|
| Payout Ratio | - | 296.89% | - | - | - | 204.10% | Upgrade
|
| Buyback Yield / Dilution | -3.81% | -34.30% | -38.27% | -19.16% | 0.13% | -0.31% | Upgrade
|
| Total Shareholder Return | -1.60% | -32.24% | -35.53% | -12.43% | 0.13% | 0.74% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.